Effect of Certolizumab Pegol Over 48 Weeks on Signs and Symptoms in Patients with Psoriatic Arthritis with and without Prior Tumor Necrosis Factor Inhibitor Exposure
Author(s):
Mease, P.; Maldonado, M.; Wollenhaupt, J.; Deodhar, A.; Gladman, D.; Stach, C.; Hoepken, B.; Peterson, L.; Heijde, D. van der
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-07-31
Language
English
Is part of
Journal of Rheumatology (2014), Vol. 41, no. 7, p. 1448-1449
